期刊文献+

外周血Tim-3表达水平与食管癌放化疗敏感性的相关性研究 被引量:2

The Correlation Between Expression of Tim-3 in Peripheral Blood and Chemoradiotherapy Sensitivity of Esophageal Carcinoma
下载PDF
导出
摘要 目的:研究T细胞免疫球蛋白黏蛋白3(Tim-3)表达水平与食管癌(EC)放化疗敏感性的相关性。方法:所有研究对象为2017年1月到2019年12月期间就诊我院的首次确诊EC患者,收集其病理标本及病理资料。采用免疫组化法检测Tim-3蛋白在EC组织和癌旁组织标本的表达,流式细胞技术检测外周血Tim-3水平。比较癌旁组织和EC组织中Tim-3蛋白表达情况,并分析其与EC病理相关参数间的关系;绘制Kaplan-Meier生存曲线进一步评估Tim-3蛋白表达与患者总生存时间(OS)及无病生存时间(DFS)的关系;通过COX多因素回归分析EC预后与Tim-3蛋白表达的关系;绘制Tim-3对EC预后的ROC曲线,并计算曲线下面积(AUC)。结果:经同步放化疗后,所有患者分为敏感组(36例)和抗拒组(42例)。Tim-3在EC组织中高表达(85.90%),而癌旁组织中轻度表达为(10.26%),差异具有统计学意义(P<0.05)。EC组织中Tim-3的异常表达在浸润深度、淋巴结转移及TNM分期具有显著差异(P<0.05),且高表达的Tim-3的患者具有更低的OS及DFS(P<0.05)。COX回归分析可知,Tim-3高表达(HR=4.253,95%CI 1.464-12.353)是影响EC患者放化疗敏感性的独立危险因素。ROC曲线下面积为0.848,预测的灵敏度为86.2%,特异度为76.3%。结论:Tim-3蛋白在放化疗抗拒EC患者癌症组织及血清中高表达,与EC放化疗敏感性存在一定的相关性,可作为预测EC的特异性标志物。 Objective:To investigate the correlation between the expression of T cell immunoglobulin mucin 3(Tim-3)and chemoradiotherapy sensitivity of esophageal carcinoma(EC).Methods:Patients who admitted our hospital from January 2017 to December 2019 were diagnosed EC,and their pathological specimens and pathological data were collected.Immunohistochemistry was used to detect the expression of Tim-3 protein in EC tissues and adjacent tissues.Flow cytometry was used to detect the level of Tim-3 in peripheral blood.The relationship between the expression of Tim-3 protein and the pathological parameters of EC was analyzed.The Kaplan Meier survival curve was plotted to further evaluate the relationship between expression of Tim-3 protein and overall survival(OS)and disease-free survival(DFS).The relationship between the prognosis of EC and the expression of Tim-3 protein was analyzed by COX regression analysis.The ROC curve of Tim-3 on the prognosis of EC was plotted,and the area under the curve(AUC)was calculated.Results:After concurrent chemoradiotherapy,patients were divided into sensitive group(36 cases)and resistance group(42 cases).The expression of Tim-3 was high in EC tissues(85.90%),while it was slightly expressed in paracancerous tissues(10.26%).The difference was statistically significant(P<0.05).The abnormal expression of Tim-3 in EC was significantly different in depth of invasion,lymph node metastasis and TNM stage(P<0.05),and patients with high expression of Tim-3 had lower OS and DFS(P<0.05).COX regression analysis showed that high expression of Tim-3(HR=4.253,95%CI 1.464-12.353)was an independent risk factor for chemoradiotherapy sensitivity in EC patients.The area under ROC curve was 0.848,the sensitivity and specificity of prediction were 86.2%and 76.3%,respectively.Conclusion:Tim-3 protein is highly expressed in cancer tissues and serum of EC patients resistant to radiotherapy and chemotherapy,which has a certain correlation with the sensitivity of EC to radiotherapy and chemotherapy,and can be used as a specific marker to predict EC.
作者 赵春燕 唐嘉迎 ZHAO Chunyan;TANG Jiaying(Dazu People's Hospital in Chongqing, Chongqing Dazu District 402360, China)
出处 《河北医学》 CAS 2021年第6期886-892,共7页 Hebei Medicine
基金 国家自然科学基金项目,(编号:81703057)。
关键词 T细胞免疫球蛋白黏蛋白3 食管癌 放化疗 Tim-3 Esophageal cancer Chemoradiotherapy
  • 相关文献

参考文献10

二级参考文献64

  • 1邵令方,高宗人,卫功铨,许金良,陈明耀,王文光.食管癌和贲门癌外科治疗进展──9107例资料分析[J].中华胸心血管外科杂志,1994,10(1):41-43. 被引量:185
  • 2孙克林,张汝刚,张大为,黄国俊,汪良骏,张德超,杨林,程贵余.食管癌淋巴结转移对手术治疗预后的影响[J].中华外科杂志,1995,33(4):222-224. 被引量:24
  • 3Cunningham D,Allum WH,Stenning SP,菅鑫妍.手术期间化学疗法与单独手术治疗可切除的胃食管癌疗效比较[J].中国处方药,2006,5(8):59-60. 被引量:434
  • 4彭国平,孙雯,孙箴,朱嘉珺,李淑萍,陈智.HBV感染患者外周血T细胞PD-1基因表达水平的变化与意义[J].浙江大学学报(医学版),2007,36(6):553-560. 被引量:11
  • 5Yuichiro Doki M.D.,Osamu Ishikawa M.D.,Ko Takachi M.D.,Isao Miyashiro M.D.,Yo Sasaki M.D.,Hiroaki Ohigashi M.D.,Kohei Murata M.D.,Terumasa Yamada M.D.,Shingo Noura M.D.,Hidetoshi Eguchi M.D.,Toshiyuki Kabuto M.D.,Shingi Imaoka M.D..Association of the Primary Tumor Location with the Site of Tumor Recurrence after Curative Resection of Thoracic Esophageal Carcinoma[J]. World Journal of Surgery . 2005 (6)
  • 6Teruo Kakegawa.Forty years’ experience in surgical treatment for esophageal cancer[J]. International Journal of Clinical Oncology . 2003 (5)
  • 7J. R. Siewert,H. J. Stein.Lymph-node dissection in squamous cell esophageal cancer – who benefits?[J]. Langenbeck’s Archives of Surgery . 1999 (2)
  • 8Fang WT,Chen WH.Current trends in extended lymph node dis-section for esophageal carcinoma. Asian Cardiovasc ThoracAnn . 2009
  • 9Bogoevski D,Onken F,Koenig A,et al.Is it ti me for a new TNMclassification in esophageal carcinoma?. Annals of Surgery . 2008
  • 10BP Wijnhoven,KT Tran,A Esterman.An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Annals of Surgery . 2007

共引文献305

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部